cV5 Diagnostic Ultrasound System vs Tempus ECG-Low EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Samsung Medison
VS
by Tempus

AI Verdict

Tool A is a versatile, AI-assisted ultrasound system providing high-quality imaging and workflow enhancements across multiple specialties, including cardiology, for comprehensive diagnostic assessment. Tool B is a specialized AI software designed to analyze ECGs specifically for the detection of low left ventricular ejection fraction. While both contribute to cardiac evaluation, they serve different functions: Tool A for broad imaging diagnostics, and Tool B for targeted ECG-based screening for a specific cardiac condition.

Choose cV5 Diagnostic Ultrasound System if…

Choose the Samsung cV5 Diagnostic Ultrasound System if your practice requires a versatile, high-quality imaging solution for comprehensive diagnostic assessments across multiple specialties like cardiology, OB/GYN, and radiology. This system is ideal for real-time visualization, detailed anatomical and functional analysis, and leveraging AI-assisted tools for enhanced image quality and workflow efficiency.

View cV5 Diagnostic Ultrasound System →

Choose Tempus ECG-Low EF if…

Choose Tempus ECG-Low EF if your clinical workflow needs an efficient, AI-powered tool for early risk stratification and identification of patients 40 years or older at risk of heart failure due to low left ventricular ejection fraction. This software is best suited for quickly analyzing standard 12-lead ECGs to provide a binary output, guiding clinicians on which patients may require further cardiac evaluation.

View Tempus ECG-Low EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cV5 Diagnostic Ultrasound System Tempus ECG-Low EF
Deployment On-premise (ultrasound system) Integrates with current ECG platforms and electronic health records (EHRs).
FDA Status Cleared AI-estimated Cleared AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cV5 Diagnostic Ultrasound System Tempus ECG-Low EF
Product Name cV5 Diagnostic Ultrasound System Tempus ECG-Low EF
Company Samsung Medison Co. Tempus AI
Description The Samsung cV5 Diagnostic Ultrasound System is a versatile, AI-assisted ultrasound solution offering high-quality imaging, streamlined workflows, and ergonomic design for confident decision-making across various medical specialties. Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation.
Primary Function Versatile, AI-assisted ultrasound for high-quality imaging across various medical specialties. AI software analyzing 12-lead ECGs to detect signs of low LVEF (u226440%) in patients 40+ at risk of heart failure.
Key AI Features HeartAssistu2122, AutoEF, Strain+, TMAD, AutoIMT+, ArterialAnalysisu2122, EzExam+u2122, EzCompareu2122, EzPrepu2122, SonoSyncu2122, QuickScanu2122, BiometryAssistu2122 AI-powered algorithm for ECG analysis, detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%)
Target Patient Population Not specified Patients 40 years or older at risk of heart failure

Videos

Demos, reviews, and walkthroughs featuring cV5 Diagnostic Ultrasound System and Tempus ECG-Low EF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.